ScoreWhy is Lipigon Pharmaceuticals AB ?
1
The company has declared Negative results for the last 3 consecutive quarters
- NET PROFIT(HY) At SEK -16.1 MM has Grown at -125.6%
- ROCE(HY) Lowest at -214.34%
- DEBTORS TURNOVER RATIO(HY) Lowest at 0.23 times
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -97.37%, its profits have fallen by -74.2%
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -97.37% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Lipigon Pharmaceuticals AB for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Lipigon Pharmaceuticals AB
-100.0%
-0.58
166.45%
OMX Stockholm 30
11.31%
0.59
18.59%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-84.89%
EBIT Growth (5y)
14.20%
EBIT to Interest (avg)
-17.57
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
0.53
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.67
EV to EBIT
-1.62
EV to EBITDA
-1.63
EV to Capital Employed
-22.70
EV to Sales
43.57
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-157.12%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET PROFIT(HY)
Higher at SEK -16.1 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
EPS(Q)
Highest at SEK -0.01
-11What is not working for the Company
NET PROFIT(HY)
At SEK -16.1 MM has Grown at -125.6%
ROCE(HY)
Lowest at -214.34%
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.23 times
Here's what is working for Lipigon Pharmaceuticals AB
Net Profit
Higher at SEK -16.1 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (SEK MM)
EPS
Highest at SEK -0.01
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (SEK)
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Lipigon Pharmaceuticals AB
Net Profit
At SEK -16.1 MM has Grown at -125.6%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (SEK MM)
Debtors Turnover Ratio
Lowest at 0.23 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
